E-drug: Advertising in online journals (cont)
---------------------------------------------
I have come across a way of online marketing that differs from those
described in the Wall Street Journal article submitted by Joel
Lexchin (March 28). It goes like this:
Experts are invited to write reviews of various medical topics for a
sponsor & advertisement-financed website for physicians.
Pharmaceutical companies are asked if they want to place
advertisements above the reviews. The review authors receive their
payment only after a company has agreed to place an ad by their
review. The ads are accompanied by a text that reads "The advertising
company has no influence over the content of [site's name]".
In my view, there is a clear risk that the authors adapt the contents
of their texts in order to attract advertisements and receive their
rewards.
Staffan Svensson
Dept of Clinical Pharmacology
Sahlgrenska Univ Hospital, Gothenburg, Sweden
"Staffan Svensson" <staffan.svensson@pharm.gu.se>
--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@usa.healthnet.org
Information and archives: http://www.healthnet.org/programs/edrug.html